期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | International Immunopharmacology LetPub Score 7.4
50 ratings
Rate
Reputation 8.0 Influence 6.6 Speed 8.8 | ||||||||||||||||||||||||
期刊簡稱 | INT IMMUNOPHARMACOL | ||||||||||||||||||||||||
ISSN | 1567-5769 | ||||||||||||||||||||||||
E-ISSN | 1878-1705 | ||||||||||||||||||||||||
h-index | 98 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.journals.elsevier.com/international-immunopharmacology | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/INTIMP | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2001 | ||||||||||||||||||||||||
每年文章數 | 1554每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 14.48% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-5769%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 2.7 month(s) 來自Elsevier的數據: Average 7.5 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 81.66% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 2.7 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[International Immunopharmacology] 的評論 | 撰寫評論 |
作者: lucky boy-5 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-30 17:17:38 評論於 How much time was given for the modification?(0) 讚! | lucky boy-5 |
作者: lucky boy-5 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-30 17:16:38 評論於 How long did it take for your major revision to be edited?(0) 讚! | lucky boy-5 |
作者: 谢大头 領域: 医学 審稿時間: 10.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-10-29 11:01:44 評論於 Received at Editorial Office 28 Jul 2024 Article revised 23 Sep 2024 Article accepted for publication 25 Oct 2024(0) 讚! | 谢大头 |
作者: wmomo 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-29 09:27:39 評論於 Hello, have you found the reviewer later? It has been almost 2 months since I started looking for one, and only one reviewer has agreed to review. How many reviewers are needed in total?(0) 讚! | wmomo |
作者: 上上强度 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-28 17:33:43 評論於 Optional open access.(0) 讚! | 上上强度 |
作者: 沃德摩尔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-25 23:58:49 評論於 Is the review process fast?(0) 讚! | 沃德摩尔 |
作者: Toby Emmie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-24 15:14:27 評論於 You can choose non-OA.(0) 讚! | Toby Emmie |
作者: 明冠力勤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-22 22:54:42 評論於 Review speed: 1.0 | Submission hit rate: 95.0 Focus on research directions: Immunology; Inflammation; Clinical experience sharing: The speed is very fast, submitted for review the next day, only minor revisions for cell experiments were accepted, grateful for the kind-hearted editor #Journal Forum#!!! #Journal Forum##Journal Forum##Journal Forum#(0) 讚! | 明冠力勤 |
作者: 明冠力勤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-22 10:43:23 評論於 Review speed: 1.0 | Submission hit rate: 95.0 Research focus: Immunology; Inflammation; Clinical experience sharing: Very fast speed, submitted for review the next day, only minor revisions accepted for cell experiments, grateful for the kind-hearted editor!!!(0) 讚! | 明冠力勤 |
作者: 8272 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-20 23:21:30 評論於 Submission must also recommend six reviewers, asking for help from the academicians, where can I find them?(0) 讚! | 8272 |
作者: 上清鸿福 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-20 21:53:18 評論於 What type of article is it?(0) 讚! | 上清鸿福 |
作者: 七伤梦玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-20 17:23:56 評論於 You can choose between OA and non-OA.(0) 讚! | 七伤梦玉 |
作者: wmomo 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-20 10:32:07 評論於 Can't find a reviewer, what should I do? It's been 2 months.(0) 讚! | wmomo |
作者: 一条小卫利 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-15 23:12:54 評論於 I am the same, waiting for the results, feeling anxious.(0) 讚! | 一条小卫利 |
作者: 饮香Sama 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-15 10:19:35 評論於 Even with added validation, the conventional prognostic model is still rejected without hesitation.(0) 讚! | 饮香Sama |
作者: drzhangzz 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-10-15 09:37:02 評論於 Submitted on July 12, 2024, revised on September 5, 2024, received back after 10 days, submitted for review on October 5, 2024, and accepted a week later. The editor was very kind, a Chinese national, and initially had trouble finding reviewers, so they kept sending me additional invitations every week until finally gathering a panel of 3 reviewers.(0) 讚! | drzhangzz |
作者: 罗宾赫林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-13 12:23:26 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Emphasized research direction: Experience sharing of traditional Chinese medicine monomers: 8.8 submissions, invited 61 people from 8-16, 6 accepted, and now 2 have completed. I don't quite understand this speed, the current status is still Required Reviews Completed. Two reviewers have already given feedback so quickly, could it be rejection feedback?(0) 讚! | 罗宾赫林 |
作者: 七步俊喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-04 17:16:28 評論於 Is there a layout fee?(0) 讚! | 七步俊喆 |
作者: 柯 領域: 环境科学与生态学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-01 22:20:24 評論於 May I ask how many reviewers the author invited to edit after "Under Review"?(0) 讚! | 柯 |
作者: 南风又薇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-21 08:16:49 評論於 Is there a layout fee?(0) 讚! | 南风又薇 |
作者: 震雷向文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-20 13:40:15 評論於 The same question.(0) 讚! | 震雷向文 |
作者: 进击的乌龟王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-15 19:30:22 評論於 I have to do the same.(0) 讚! | 进击的乌龟王 |
作者: ZF17 領域: 医学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-14 12:58:37 評論於 Hired.(0) 讚! | ZF17 |
作者: ZF17 領域: 医学 審稿時間: 12.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-14 12:57:50 評論於 Employment after modification(0) 讚! | ZF17 |
作者: 龙象利彬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-11 08:11:13 評論於 How are you doing? Mine has also been stuck on RRC for a while, urgent urgent urgent.(0) 讚! | 龙象利彬 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us